Product Description
The global autotransfusion device market was valued at $321.2 million in 2025. This is expected to increase over the forecast period at a CAGR of 1.7% to reach $360.2 million by 2032.
The full report suite on the global market for autotransfusion devices includes autotransfusion disposable kits and autotransfusion machines.
The report includes data for 65+ countries across 7 different regions, which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Autotransfusion Device Market Trends
Autotransfusion machines compete directly with allogeneic blood transfusions, which remain widely available and well established across most healthcare systems. Although autotransfusion offers clinical and safety advantages, including reduced exposure to donor blood, the high upfront capital cost of autotransfusion machines represents a significant barrier to adoption, particularly in cost-constrained hospital environments. Budget limitations and competing capital priorities often lead hospitals to continue relying on allogeneic blood rather than investing in dedicated autotransfusion equipment, especially as average selling prices for these systems increase.
Global Autotransfusion Device Market Share Insights
- LivaNova was the leading competitor in the global autotransfusion market in 2025. LivaNova has been in the market for over 30 years and launched its latest autotransfusion machine, The company has continued to invest in the autotransfusion market, giving it the expectation to expand its market share over the coming years.
- Haemonetics was the second-leading competitor in the autotransfusion market in 2025. Haemonetics currently offers the Cell Saver® Elite® and Cell Saver® Elite® + autotransfusion systems in the United States. The company is present in a limited number of cardiac surgery device market segments; as such, it is expected that the competition between LivaNova and Medtronic will reduce the company’s share in the coming years.
- Medtronic was the third-leading competitor in the global autotransfusion market in 2025. The company offers the AutoLog IQ™. A device priced at a modest premium to its predecessor, autoLog™. Medtronic also offers disposables, including filters and reservoirs for use in the autotransfusion procedure. Since Medtronic has left the ventricular assist device market, it is expected that it will expand its presence in the autotransfusion segment.
Global Autotransfusion Device Market Segmentation Summary
- Autotransfusion Device Market – Further Segmented Into:
- Device Type: Autotransfusion Machines and Autotransfusion Disposables.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis for Top Competitors, Mergers & Acquisitions, Emerging Markets & Technologies, Key Analysis Updates. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
